Biology Reference
In-Depth Information
[63] Murphy WJ, Kumar V, Bennett M. Rejection of bone marrow allografts by mice with
severe combined immune deficiency (SCID). Evidence that natural killer cells can
mediate the specificity of marrow graft rejection. J Exp Med 1987;165:1212-7.
[64] Kawai T, Wee SL, Bazin H, Latinne D, Phelan J, Boskovic S, et al. Association of natural
killer cell depletion with induction of mixed chimerism and allograft tolerance in non-
human primates. Transplantation 2000;70:368-74.
[65] Barao I, Murphy WJ. The immunobiology of natural killer cells and bone marrow
allograft rejection. Biol Blood Marrow Transplant 2003;9:727-41.
[66] Aguila HL, Weissman IL. Hematopoietic stem cells are not direct cytotoxic targets of
natural killer cells. Blood 1996;87:1225-31.
[67] Jaiswal S, Jamieson CHM, Pang WW, Park CY, Chao MP, Majeti R, et al. CD47 is upregu-
lated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.
Cell 2009;138:271-85.
[68] Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, et al. Effects of HLA allele
and killer immunoglobulin-like receptor ligand matching on clinical outcome in leuke-
mia patients undergoing transplantation with T-cell-replete marrow from an unrelated
donor. Biol Blood Marrow Transplant 2007;13:315-28.
[69] Petersdorf EW, Hansen JA, Martin PJ, Woolfrey A, Malkki M, Gooley T, et al. Major-
histocompatibility-complex class I alleles and antigens in hematopoietic-cell trans-
plantation. N Engl J Med 2001;345:1794-800.
[70] Deeg HJ, Storb R, Shulman HM, Weiden PL, Graham TC, Thomas ED. Engraftment of
DLA-nonidentical unrelated canine marrow after high-dose fractionated total body
irradiation. Transplantation 1982;33:443-6.
[71] Soderling CC, Song CW, Blazar BR, Vallera DA. A correlation between conditioning and
engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow
transplants. J Immunol 1985;135:941-6.
[72] Prigozhina TB, Gurevitch O, Slavin S. Nonmyeloablative conditioning to induce bi-
lateral tolerance after allogeneic bone marrow transplantation in mice. Exp Hematol
1999;27:1503-10.
[73] Mapara MY, Pelot M, Zhao G, Swenson K, Pearson D, Sykes M. Induction of stable long-
term mixed hematopoietic chimerism following nonmyeloablative conditioning with T
cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-
speciic in vitro and in vivo tolerance. Biol Blood Marrow Transplant 2001;7:646-55.
[74] Raziuddin A, Longo DL, Bennett M, Winkler-Pickett R, Ortaldo JR, Murphy WJ. In-
creased bone marrow allograft rejection by depletion of NK cells expressing inhibitory
Ly49 NK receptors for donor class I antigens. Blood 2002;100:3026-33.
[75] He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, et al. T cell-de-
pendent production of IFN-gamma by NK cells in response to influenza A virus. J Clin
Invest 2004;114:1812-9.
[76] Shanker A, Verdeil G, Buferne M, Inderberg-Suso EM, Puthier D, Joly F, et al. CD8 T cell
help for innate antitumor immunity. J Immunol 2007;179:6651-62.
[77] Grayson JM, Zajac AJ, Altman JD, Ahmed R. Cutting edge: increased expression of Bcl-2
in antigen-specific memory CD8+ T cells. J Immunol 2000;164:3950-4.
[78] Yao Z, Jones J, Kohrt H, Strober S. Selective resistance of CD44hi T cells to p53-depen-
dent cell death results in persistence of immunologic memory after total body irradia-
tion. J Immunol 2011;187:4100-8.
[79] Nagata S, Okano S, Yonemitsu Y, Nakagawa K, Tomita Y, Yoshikai Y, et al. Critical roles of
memory T cells and antidonor immunoglobulin in rejection of allogeneic bone marrow
cells in sensitized recipient mice. Transplantation 2006;82:689-98.
[80] Lan F, Zeng D, Higuchi M, Huie P, Higgins JP, Strober S. Predominance of NK1.1+TCR
alpha beta + or DX5 + TCR alpha beta + T cells in mice conditioned with fractionated lym-
phoid irradiation protects against graft-versus-host disease: “natural suppressor” cells.
J Immunol 2001;167:2087-96.
[81] Pillai AB, George TI, Dutt S, Strober S. Host natural killer T cells induce an interleukin-
4-dependent expansion of donor CD4 + CD25 + Foxp3 + T regulatory cells that protects
against graft-versus-host disease. Blood 2009;113:4458-67.
[82] Gale RP, Ho W, Feig S, Champlin R, Tesler A, Arenson E, et al. Prevention of graft rejec-
tion following bone marrow transplantation. Blood 1981;57:9-12.
[83] Ramsay NK, Kim TH, McGlave P, Goldman A, Nesbit Jr ME, Krivit W, et al. Total lym-
phoid irradiation and cyclophosphamide conditioning prior to bone marrow trans-
plantation for patients with severe aplastic anemia. Blood 1983;62:622-6.
[84] Storb R, Weiden PL, Sullivan KM, Appelbaum FR, Beatty P, Buckner CD, et al. Second
marrow transplants in patients with aplastic anemia rejecting the first graft: use of a
conditioning regimen including cyclophosphamide and antithymocyte globulin. Blood
1987;70:116-21.
118
Search WWH ::




Custom Search